The biotech bull market is not over. That's the judgment of Reni Benjamin of H.C. Wainwright & Co., who predicts high quality data from a broad range of small- and mid-cap biotechs will
This market is tough to hold down for even a day or two. That’s bull market stuff. While many on the Street think a correction is justified, the bulls aren’t interested. I agree, a 3% t0 5%
Shares of Celsion Corporation (CLSN) are taking a beating Thursday morning after the company said that its phase III HEAT trial of ThermoDox for hepatocellular carcinoma, or liver cancer, failed
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Celsion Corp is active in the biotechnology sector. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in a clinical trial for the treatment of primary liver cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers.
| Website: | www.celsion.com |
| Email: | Sam@argotpartners.com |
| Main Phone: | +1 609 896-9100 |
| Address: | 997 Lenox Drive |
| Address 2: | Suite 100 |
| State: | NJ |
| City / Town: | Lawrenceville |
| Country: | US |
| Postal Code: | 08648 |
| Exchange: | NSC |
| CEO: | Michael H. Tardugno |
| Employees: | 27 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
The biotech bull market is not over. That's the judgment of Reni Benjamin of H.C. Wainwright & Co., who predicts high quality data from a broad range of small- and mid-cap biotechs will
This market is tough to hold down for even a day or two. That’s bull market stuff. While many on the Street think a correction is justified, the bulls aren’t interested. I agree, a 3% t0 5%
Shares of Celsion Corporation (CLSN) are taking a beating Thursday morning after the company said that its phase III HEAT trial of ThermoDox for hepatocellular carcinoma, or liver cancer, failed
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
